Tagged: #phaseiitrialofpembrolizumab

Principal investigator Trisha Wise-Draper, MD, PhD, assistant professor of medicine, division of hematology/oncology, at the University of Cincinnati Medical Center, says she is “hoping for at least a 10% increase in the survival rate” for patients with head and neck squamous cell cancer in a Phase II trial of pembrolizumab being led by University of

Learn More →